Health & Fitness
Health and Fitness
Health and Fitness
Mon, January 17, 2011Fri, January 14, 2011Thu, January 13, 2011Wed, January 12, 2011Tue, January 11, 2011Mon, January 10, 2011Sun, January 9, 2011Fri, January 7, 2011Thu, January 6, 2011Wed, January 5, 2011Tue, January 4, 2011Mon, January 3, 2011Fri, December 31, 2010Thu, December 30, 2010Wed, December 29, 2010Tue, December 28, 2010Mon, December 27, 2010Fri, December 24, 2010Thu, December 23, 2010Wed, December 22, 2010Tue, December 21, 2010Mon, December 20, 2010Fri, December 17, 2010Thu, December 16, 2010Wed, December 15, 2010Tue, December 14, 2010Derma Sciences Launches Advanced Wound Care eLearning Portal for Clinicians
Published in Health and Fitness on Tuesday, January 4th 2011 at 7:25 GMT by Market Wire
PRINCETON, N.J.--([ BUSINESS WIRE ])--Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces the launch of a new eLearning Portal to provide clinicians with valuable educational programs to ensure they are kept abreast of the latest information and product solutions in the Companya™s advanced wound care line. Available at [ www.dermasciences.com/elearning-portal/ ], the eLearning Portal is a highly visible example of the Derma Sciences commitment to advanced wound care, and contains both new and aggregated content.
The eLearning Portal includes archived webinars to support educational needs on such topics as wound debridement, the use of MEDIHONEY® on stalled wounds and those with atypical etiologies, and the benefits of super absorbent polymer technology in moist wound dressings. New webinars will be added approximately every six weeks. The Portal also aggregates the considerable number of abstracts, articles and peer-reviewed clinical posters on MEDIHONEY®, as well as broadcast media coverage about the Companya™s products and extensive product literature available for download on MEDIHONEY®, XTRASORB®, ALGICELL® Ag and BIOGUARD®. Clinicians also can request product samples directly from the eLearning Portal.
According to Barry Wolfenson, Executive Vice President, Global Marketing and Business Development at Derma Sciences, aWith the launch of our new eLearning Portal we are able to bring current and actionable information to clinicians who strive daily to deliver the highest quality care to patients with chronic wounds, burns and wounds at risk of infection. We will be adding content regularly, which will help our customers stay abreast of the many ways in which our innovative products are helping to advance the practice of wound care.a
About Derma Sciences, Inc.
Derma Sciences is a medical technology company focused on three segments of the wound care marketplace, including traditional dressings, advanced wound care dressings and pharmaceutical wound care products. Its MEDIHONEY® product is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of indications, and was the focus of a positive large-scale, randomized controlled trial involving 108 patients with leg ulcers. Other novel products introduced into the $14 billion global wound care market include XTRASORB®, an advanced line of moist wound dressings, and BIOGUARD® for infection prevention. Derma Sciences expects to announce top-line efficacy results of its Phase 2 clinical study with DSC127, a novel pharmaceutical for accelerated wound healing and scar reduction, by the end of January 2011.
For more information please visit [ www.dermasciences.com ].
Forward-Looking Statements
Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release or that are otherwise made by or on behalf of the Company. Factors that may affect the Company's results include, but are not limited to, product demand, market acceptance, impact of competitive products and prices, product development, completion of an acquisition, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include but are not limited to, those discussed in the Company's fillings with the U.S. Securities and Exchange Commission.
